Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RANOLAZINE vs REBOXETINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RANOLAZINE vs REBOXETINE: Safety Overview

Metric RANOLAZINE REBOXETINE
Total FAERS Reports 9,522 185
Deaths Reported 1,048 19
Death Rate 11.0% 10.3%
Hospitalizations 3,367 63
Average Patient Age 70.4 yrs 53.6 yrs
% Female Patients 42.0% 62.7%
FDA Approval Date Apr 15, 2025 N/A
Manufacturer AvKARE N/A
Route ORAL N/A
Marketing Status Discontinued N/A